Arkolith/Insider Trading/FBIO/Form 4

Rosenwald Lindsay A MD

PRESIDENT, CEO & CHAIRMAN, Director, 10% OwnerFortress Biotech, Inc. (FBIO) · full profile →Form 4 · filed Apr 29, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 1, 2022Grant(A)1.1M—$011.5M
Dec 1, 2021Grant(A)1K$2.42$3K10.4M
Nov 16, 2021Other(J)5K—$010.4M
Sep 30, 2021Other(J)8K—$010.4M
Jun 1, 2021Grant(A)1K$2.31$3K10.4M

Transaction Codes

A
Grant / award
J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-053615) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML